February 21, 2025

Oyster Proteins Supercharge Common Antibiotics' Power

New research reveals that antimicrobial proteins extracted from Sydney Rock Oyster hemolymph can enhance conventional antibiotic effectiveness up to 32-fold against drug-resistant bacteria while showing no toxicity to human cells.

Conexiant

February 20, 2025

Hospital Occupancy to Reach 85% by 2035

The projection is driven by a decline in staffed beds and an aging population.

Conexiant

February 19, 2025

Hospital Occupancy to Reach 85% by 2035

The projection is driven by a decline in staffed beds and an aging population.

Conexiant

February 18, 2025

FDA Clears Aptima SARS-CoV-2 Assay for High-Throughput Testing

FDA grants 510(k) clearance for Hologic’s Aptima SARS-CoV-2 assay, which uses the Panther system for high-throughput RNA detection.

Conexiant

February 14, 2025

Study: Patients Trust Female Docs Less

Study findings and an interview with the lead investigator.

Conexiant

February 03, 2025

Vascular Access Strategies for Cardiac Arrest

No significant difference in survival or neurologic outcomes between intraosseous and intravenous vascular access in out-of-hospital cardiac arrest was found.

Conexiant

February 03, 2025

PICU Delay Linked to Dialysis Dependency

Researchers analyze kidney replacement therapies in pediatric crush syndrome. Their findings emphasized dialysis dependency and pediatric intensive care unit outcomes post-earthquake.

Conexiant

January 31, 2025

Cost-Effectiveness of Shortened Antibiotic Treatment for VAP

Researchers conducted a planned economic analysis of the phase IV REGARD-VAP trial, which assessed a short-course antibiotic treatment strategy for ventilator-associated pneumonia.

Conexiant

January 24, 2025

VA Study Maps GLP-1 Effects Across Systems

Large-scale study of 1.9M veterans identifies previously unreported benefits and risks of GLP-1 receptor agonists across 175 health outcomes, including reduced substance use disorders and increased pancreatitis risk.

Conexiant